By John Kariuki
In a push to raise awareness about the prevention of cervical cancer, Dr. Kireki Omanwa, the President of the Kenya Obstetrical and Gynaecological Society (KOGS), is urging the public to prioritize the Human Papillomavirus (HPV) vaccine. HPV is a leading cause of cervical cancer, a deadly condition that affects women globally.
Speaking on Monday, Dr. Kireki explained the risks posed by HPV, a virus transmitted through sexual activity. While some strains of HPV cause genital warts, others can lead to serious cancers, including cervical cancer. According to Dr. Kireki, the HPV vaccine is key in preventing both genital warts and various types of cancer caused by the virus, including cancer of the vagina and genital areas.
“The HPV vaccine helps the immune system recognize certain strains of HPV, making it easier to eliminate them if a person is exposed later in life,” said Dr. Kireki.
The World Health Organization (WHO) has approved the HPV vaccine, and it is recommended for individuals aged 9 and above, with the ideal vaccination age being 11 or 12. Dr. Kireki emphasized that vaccinating at a younger age, particularly before sexual activity begins, offers the best protection. While the vaccine is most effective in preventing new infections, it may be less effective if a person already has HPV.
For younger individuals under the age of 15, the vaccine requires just two doses, given 6 to 12 months apart. Those between the ages of 15 and 26 will need three doses, administered over six months. For those who have not been vaccinated by age 26, catch-up vaccinations are still encouraged. Importantly, the vaccine is safe for both males and females, ranging from ages 9 to 45.
Dr. Kireki clarified that while the HPV vaccine is a crucial tool in preventing cervical cancer, it does not replace regular Pap tests. Women should begin screening for cervical cancer with Pap tests starting at age 21 as part of their ongoing healthcare routine.
Dr. Kireki also encouraged individuals to seek medical attention immediately if they notice any potential symptoms of cervical cancer. Warning signs may include vaginal bleeding after sex, between periods, or after menopause, as well as pelvic pain or pain during intercourse.
With continued efforts to promote HPV vaccination, Dr. Kireki and KOGS hope to reduce the burden of cervical cancer in Kenya and beyond.